tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
ACAD is currently covered by 19 analysts with an average price target of $31.97. This is a potential upside of $11.5 (56.18%) from yesterday's end of day stock price of $20.47.
ACADIA Pharmaceuticals's activity chart (see below) currently has 596 price targets and 486 ratings on display. The stock rating distribution of ACAD is 79.63% BUY and 20.37% HOLD.
Analysts average stock forecasts to be materialized ratio is 57.5% with an average time for these price targets to be met of 255.15 days.
Highest price target for ACAD is $49, Lowest price target is $20, average price target is $31.97.
Most recent stock forecast was given by AMI FADIA from NEEDHAM on 19-Oct-2026. First documented stock forecast 21-Mar-2013.
Currently out of the existing stock ratings of ACAD, 43 are a BUY (79.63%), 11 are a HOLD (20.37%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Feb-2024
$35
$14.41 (69.99%)
$35
14 days ago
(19-Oct-2026)
9/16 (56.25%)
$15.2 (76.77%)
393
Buy Since 23-Jun-2025
$36
$15.41 (74.84%)
$37
25 days ago
(08-Oct-2026)
1/10 (10%)
$16.42 (83.86%)
173
Buy Since 15-Dec-2025
$33
$12.41 (60.27%)
$37
1 months 8 days ago
(25-Sep-2026)
0/3 (0%)
$12.32 (59.57%)
Buy Since 17-Apr-2025
$34
$13.41 (65.13%)
$36
1 months 8 days ago
(25-Sep-2026)
4/6 (66.67%)
$13.32 (64.41%)
144
Buy Since 25-Sep-2025
$31
$10.41 (50.56%)
$38
1 months 8 days ago
(25-Sep-2026)
1/4 (25%)
$10.32 (49.90%)
831
What is ACAD (ACADIA Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on ACAD (ACADIA Pharmaceuticals)?
Which analyst has the most public recommendations on ACAD (ACADIA Pharmaceuticals)?
Which analyst is the currently most bullish on ACAD (ACADIA Pharmaceuticals)?
Which analyst is the currently most reserved on ACAD (ACADIA Pharmaceuticals)?
